Search

Your search keyword '"LEVODOPA"' showing total 28,120 results

Search Constraints

Start Over You searched for: Descriptor "LEVODOPA" Remove constraint Descriptor: "LEVODOPA"
28,120 results on '"LEVODOPA"'

Search Results

6. Chronic intracranial recordings in the globus pallidus reveal circadian rhythms in Parkinsons disease.

7. Immediate Effects of High-Cadence Cycling on Core Outcomes in Individuals With Parkinson's Disease.

10. Role of Pentoxifylline and Celecoxib in Parkinsonism

18. Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials.

19. Abdominal Tremor in Idiopathic Parkinson’s Disease: A Case Report

29. Novel Non-opioid Post-surgical Pain Treatment in Females

36. Greenness and whiteness appraisal for bioanalysis of quetiapine, levodopa and carbidopa in spiked human plasma by high performance thin layer chromatography.

37. Rate of motor progression in Parkinson's disease: a systematic review and meta-analysis.

38. Sublingual apomorphine in the treatment of Parkinson's disease.

39. Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta‐Analysis.

40. Effect of Early Levodopa Treatment on Mortality in People with Parkinson's Disease.

41. Simultaneous sensing of carbidopa and levodopa by a novel strategy based on dual‐emission ratiometric assay of modified carbon dots.

42. Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.

43. Associations between Constipation and Use of Levodopa with Nutritional Status, Polypharmacy, and Stage of Parkinson's Disease.

44. L-DOPA increases slow-wave sleep duration and selectively modulates memory persistence in older adults.

45. Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.

46. Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion.

47. Dopa Responsiveness in Parkinson's Disease.

48. Boosting endogenous dopamine production: a novel therapeutic approach for Parkinson's disease.

49. Can we add whey protein supplementation in patients with Parkinson's disease without interfering with levodopa response?

50. Dopamine and its precursor levodopa inactivate SARS-CoV-2 main protease by forming a quinoprotein.

Catalog

Books, media, physical & digital resources